Section Arrow
Quote
NBY.NYSE-M
- NovaBay Pharmaceuticals
Quotes are at least 15-min delayed:2026/03/02 22:54 EST
Regular Hours
Last
 1.43
-0.01 (-0.69%)
Day High 
1.699 
Prev. Close
1.44 
1-M High
12.4 
Volume 
470.31K 
Bid
1.44
Ask
1.67
Day Low
1.29 
Open
1.35 
1-M Low
1.39 
Market Cap 
186.64M 
Currency 美元 
P/E 0.05 
%Yield 279.72 
10-SMA 2.13 
20-SMA 3.53 
50-SMA 22.32 
52-W High 99.75 
52-W Low 1.39 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
30.95/-0.86
Enterprise Value
187.35M
Balance Sheet
Book Value Per Share
-0.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.78M
Operating Revenue Per Share
0.12
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.44+0.64+6.53%-- 
QNCXQuince Therapeutics0.0988-0.0213-17.74%-- 
OCULOcular Therapeutix10.98+2.035+22.75%-- 
QUREuniQure NV10.5-5.08-32.61%-- 
GERNGeron Corp1.55-0.13-7.74%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.